Dr. Bernard A. Fox is a pioneering translational cancer immunotherapist, biotech entrepreneur, and academic currently serving as Chair of the World Immunotherapy Council and as a Visiting Professor at both Sun Yat-sen University and National Taiwan University College of Medicine. With a distinguished career that includes founding UbiVac, a clinical stage immuno-oncology company, and holding significant roles at the Society for Immunotherapy of Cancer, Dr. Fox has greatly advanced the development of effective immunotherapy strategies. They have contributed to the field through various positions, including Senior Staff Fellow at the National Cancer Institute and Faculty at the University of Michigan Medical School, where they pioneered autologous tumor vaccination approaches. With a commitment to improving cancer patient outcomes, Dr. Fox continues to shape the future of cancer treatment and research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices